| Revenue growth | -10.9% YoY |
|---|---|
| Margins | EBITDA margin -60.3% due to one-off expenses; PAT margin 28.3% (one-offs). |
| Demand visibility | Healthy recovery expected in API and institution business this fiscal. |
| Management confidence | Optimistic on improving business momentum and operational efficiencies. |
Growth
Revenue declined 10.9% YoY to ₹86.96 Cr; PAT turned positive at ₹24.6 Cr vs loss of ₹14.2 Cr.
Outlook
Focusing on hospital segment leadership and complex injectables; targeting RoW markets (0-3 years) and regulated markets (3-5 years).
Risks
API business headwinds causing top-line contraction; inventory price adjustments and one-off expenses impacted operational margins.
Investor Presentation filed with BSE, NSE: THEMISMED. Summary written with AI assistance from the document.
Themis Medicare Ltd: key numbers
- Share price
- ₹116.93
- Market cap
- ₹1,077 Cr
- Revenue (annual)
- ₹342.2 Cr
- Net profit (annual)
- ₹1.14 Cr
- P/E (TTM)
- 26.9×Sector 50.4×
- Promoter holding
- 67.11%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Themis Medicare Ltd
All →Themis Medicare Capital Structure Change
Themis Medicare Ltd withdrew its proposed preferential issue of 45,95,795 warrants. The company secured working capital through alternative means, and no adverse impact is expected.
Themis Medicare Dividend
Themis Medicare fixed the record date as September 23, 2026, for its final dividend FY 2025-26, pending AGM approval on September 30, 2026. No dividend per-share amount is stated.
Themis Medicare Annual General Meeting
Themis Medicare Limited has issued the notice for its upcoming Annual General Meeting scheduled for September 30, 2026. Shareholders will consider resolutions including dividend declaration.
Themis Medicare Annual Report
Themis Medicare Limited has filed its Annual Report for the financial year 2025-26, along with the notice for its 56th Annual General Meeting.
Themis Medicare Price Movement Clarification
Themis Medicare Limited has clarified to the exchange that there is no pending or delayed material information regarding the recent increase in trading volume.
Themis Medicare Q1 FY27 Results: Turns Profitable, Net Profit ₹24.6 Cr
Themis Medicare Ltd reported revenue from operations of ₹87 Cr (-10.9% YoY) and net profit of ₹24.6 Cr for Q1 FY27.
- Key figure
- Net profit ₹24.6 Cr